Matches in Wikidata for { <http://www.wikidata.org/entity/Q49968542> ?p ?o ?g. }
- Q49968542 description "2018 nî lūn-bûn" @default.
- Q49968542 description "2018 թվականի փետրվարի 12-ին հրատարակված գիտական հոդված" @default.
- Q49968542 description "2018年の論文" @default.
- Q49968542 description "2018年学术文章" @default.
- Q49968542 description "2018年学术文章" @default.
- Q49968542 description "2018年学术文章" @default.
- Q49968542 description "2018年学术文章" @default.
- Q49968542 description "2018年学术文章" @default.
- Q49968542 description "2018年学术文章" @default.
- Q49968542 description "2018年學術文章" @default.
- Q49968542 description "2018年學術文章" @default.
- Q49968542 description "2018年學術文章" @default.
- Q49968542 description "2018年學術文章" @default.
- Q49968542 description "2018年學術文章" @default.
- Q49968542 description "2018년 논문" @default.
- Q49968542 description "article científic" @default.
- Q49968542 description "article scientific" @default.
- Q49968542 description "article scientifique" @default.
- Q49968542 description "articol științific" @default.
- Q49968542 description "articolo scientifico" @default.
- Q49968542 description "artigo científico" @default.
- Q49968542 description "artigo científico" @default.
- Q49968542 description "artigo científico" @default.
- Q49968542 description "artikel ilmiah" @default.
- Q49968542 description "artikull shkencor" @default.
- Q49968542 description "artikulong pang-agham" @default.
- Q49968542 description "artykuł naukowy" @default.
- Q49968542 description "artículo científico publicado en 2018" @default.
- Q49968542 description "artículu científicu" @default.
- Q49968542 description "bilimsel makale" @default.
- Q49968542 description "bài báo khoa học" @default.
- Q49968542 description "naučni članak" @default.
- Q49968542 description "scienca artikolo" @default.
- Q49968542 description "scientific article published on 12 February 2018" @default.
- Q49968542 description "scientific article published on 12 February 2018" @default.
- Q49968542 description "scientific article published on 12 February 2018" @default.
- Q49968542 description "teaduslik artikkel" @default.
- Q49968542 description "tieteellinen artikkeli" @default.
- Q49968542 description "tudományos cikk" @default.
- Q49968542 description "vedecký článok" @default.
- Q49968542 description "vetenskaplig artikel" @default.
- Q49968542 description "videnskabelig artikel" @default.
- Q49968542 description "vitenskapelig artikkel" @default.
- Q49968542 description "vitskapeleg artikkel" @default.
- Q49968542 description "vědecký článek" @default.
- Q49968542 description "wetenschappelijk artikel" @default.
- Q49968542 description "wissenschaftlicher Artikel" @default.
- Q49968542 description "επιστημονικό άρθρο" @default.
- Q49968542 description "мақолаи илмӣ" @default.
- Q49968542 description "наукова стаття, опублікована в лютому 2018" @default.
- Q49968542 description "научна статия" @default.
- Q49968542 description "научная статья" @default.
- Q49968542 description "научни чланак" @default.
- Q49968542 description "научни чланак" @default.
- Q49968542 description "מאמר מדעי" @default.
- Q49968542 description "مقالة علمية نشرت في 12 فبراير 2018" @default.
- Q49968542 description "১২ ফেব্রুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q49968542 description "บทความทางวิทยาศาสตร์" @default.
- Q49968542 description "სამეცნიერო სტატია" @default.
- Q49968542 name "A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results." @default.
- Q49968542 name "A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results." @default.
- Q49968542 type Item @default.
- Q49968542 label "A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results." @default.
- Q49968542 label "A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results." @default.
- Q49968542 prefLabel "A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results." @default.
- Q49968542 prefLabel "A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results." @default.
- Q49968542 P1433 Q49968542-C064B9D3-51ED-4D99-8C42-7054B9A2CFF7 @default.
- Q49968542 P1476 Q49968542-80D09605-5A25-4721-B0C2-DF851FBC95C2 @default.
- Q49968542 P2093 Q49968542-1766742D-936C-4FCE-8AC1-03F353767646 @default.
- Q49968542 P2093 Q49968542-1A89F434-817A-452A-8021-B3296E99719D @default.
- Q49968542 P2093 Q49968542-1D0F9B8A-4AD2-4B54-A544-B46C05317579 @default.
- Q49968542 P2093 Q49968542-494D486E-18C5-4435-964D-0E8AB7FCB346 @default.
- Q49968542 P2093 Q49968542-634EC0FE-8D5D-4DBE-B288-B59AD0FC2314 @default.
- Q49968542 P2093 Q49968542-644A8957-2971-4BF0-AC0C-3715E83B8098 @default.
- Q49968542 P2093 Q49968542-88AED074-E19A-458D-8F88-6650C5B6A8AC @default.
- Q49968542 P2093 Q49968542-9699CE5F-08FB-4CD9-9D68-4972B80A637B @default.
- Q49968542 P2093 Q49968542-A3D39614-502B-44AA-8202-513C6E0CECC3 @default.
- Q49968542 P2093 Q49968542-BF220E9E-EA79-45D5-9681-C865E86356F0 @default.
- Q49968542 P2093 Q49968542-C3BBAE30-4A45-4B8E-969C-0E914F12CB5F @default.
- Q49968542 P2093 Q49968542-D0232951-52BB-4373-AB4D-EDF6FDF22B92 @default.
- Q49968542 P304 Q49968542-35A02B7E-0E85-4903-80B9-C1780D366F1B @default.
- Q49968542 P31 Q49968542-FEDD699A-B9D2-4AAC-BDDF-CACCD938C153 @default.
- Q49968542 P356 Q49968542-A97CBC23-E849-40B0-85D9-AC2C10C5702E @default.
- Q49968542 P478 Q49968542-1C00BB20-B938-49DE-A78B-F1E977091819 @default.
- Q49968542 P50 Q49968542-64F47979-E974-492A-94C3-487CAA595ED2 @default.
- Q49968542 P50 Q49968542-9DA502BB-0DAB-4A50-AF4C-DB922F44832A @default.
- Q49968542 P50 Q49968542-D0173E7D-201E-40B9-B85B-336F746FB760 @default.
- Q49968542 P50 Q49968542-F4F99F61-05F2-4794-8C19-6231F0AE842A @default.
- Q49968542 P577 Q49968542-F716C9C2-7C82-4B33-A061-1FA1CC52FA99 @default.
- Q49968542 P698 Q49968542-FD471FC2-F613-4086-8F67-71D680ACBBE2 @default.
- Q49968542 P921 Q49968542-7BE424CD-F174-4088-9795-3743DCFA09FC @default.
- Q49968542 P356 J.EJCA.2018.01.072 @default.
- Q49968542 P698 29448072 @default.
- Q49968542 P1433 Q332260 @default.
- Q49968542 P1476 "A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results" @default.
- Q49968542 P2093 "E Trishkina" @default.
- Q49968542 P2093 "I Bondarenko" @default.
- Q49968542 P2093 "J Lim" @default.
- Q49968542 P2093 "J-H Ahn" @default.
- Q49968542 P2093 "M Bello" @default.